2IUDnCT Clinical Trial Data (NCT01721798)
<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a research archivist expert in dataset metadata. Answer the question truthfully.  <|eot_id|><|start_header_id|>user<|end_header_id|> Here is the Description of a dataset. Description:'Database for analysis presented in forthcoming publication 'Safety and continued use of the levonorgestrel intrauterine system as compared with the copper intrauterine device among women living with HIV in South Africa: a randomized controlled trial' in PLoS Medicine.  Briefly, in this double-masked, randomized controlled non-inferiority trial, eligible WLHIV were: ages 18–40, not pregnant or desiring pregnancy within 30 months, screened and treated for reproductive tract infections (RTIs) within one month of enrollment, and virologically-suppressed using ART or above treatment threshold at enrollment (non-ART). Between October, 2013, and December, 2016, we randomized consenting women within ART groups, using 1:1 permuted block randomization stratified by ART use, age (18–23, 24–31, 32–40), and recent injectable progestin contraceptive ' . Please return only a json list of at most 3 Keywords corresponding to the Description:.<|eot_id|><|start_header_id|>assistant<|end_header_id|> {"Answer" : ["HIV, randomized controlled trial, intrauterine contraceptive, genital tract viral load"]} <|eot_id|>
 Here is the Description of a dataset. Description:'Database for analysis presented in forthcoming publication 'Safety and continued use of the levonorgestrel intrauterine system as compared with the copper intrauterine device among women living with HIV in South Africa: a randomized controlled trial' in PLoS Medicine.  Briefly, in this double-masked, randomized controlled non-inferiority trial, eligible WLHIV were: ages 18–40, not pregnant or desiring pregnancy within 30 months, screened and treated for reproductive tract infections (RTIs) within one month of enrollment, and virologically-suppressed using ART or above treatment threshold at enrollment (non-ART). Between October, 2013, and December, 2016, we randomized consenting women within ART groups, using 1:1 permuted block randomization stratified by ART use, age (18–23, 24–31, 32–40), and recent injectable progestin contraceptive ' . Please return only a json list of at most 3 Keywords corresponding to the Description:.
Database for analysis presented in forthcoming publication 'Safety and continued use of the levonorgestrel intrauterine system as compared with the copper intrauterine device among women living with HIV in South Africa: a randomized controlled trial' in PLoS Medicine.  Briefly, in this double-masked, randomized controlled non-inferiority trial, eligible WLHIV were: ages 18–40, not pregnant or desiring pregnancy within 30 months, screened and treated for reproductive tract infections (RTIs) within one month of enrollment, and virologically-suppressed using ART or above treatment threshold at enrollment (non-ART). Between October, 2013, and December, 2016, we randomized consenting women within ART groups, using 1:1 permuted block randomization stratified by ART use, age (18–23, 24–31, 32–40), and recent injectable progestin contraceptive 
HIV, randomized controlled trial, intrauterine contraceptive, genital tract viral load